Shown: posts 1 to 5 of 5. This is the beginning of the thread.
Posted by Keith Talent on September 15, 2006, at 4:05:57
Hi everyone,
Does anyone know how to get data on the dopamine-releasing properties of drugs from the PDSP (Psychoactive Drug Screening Program) website? I'm specifically interested in dextroamphetamine versus methylphenidate, but can't see any obvious way to extract these data. I'm interested to know because I think that the results may have implications for the sustainability of therapeutic benefits with these agents. Thanks,
KT
Posted by dbc on September 15, 2006, at 5:21:54
In reply to DA-releasing information on PDSP?, posted by Keith Talent on September 15, 2006, at 4:05:57
All i can give you is ancedotal evidence. D-amphetamine is much more potent dopamine wise than methylphenidate, the fact that (ritalin) is a racemic mixture would also lead me to this conclusion. Though relatively recently theres been a product released called focalin thats pure D-methylphenidate so that may cause quite a difference in dopamine release in higher doses. (the Levo isomer in ritalin/adderall is pretty damn useless and serves mostly as a cardiovascular stimulant).
Posted by linkadge on September 15, 2006, at 6:43:12
In reply to Re: DA-releasing information on PDSP?, posted by dbc on September 15, 2006, at 5:21:54
I don't know if PDSP has data for DA releasing properties, since I think it deals mainly with receptor affinities as antagonists or agonists.
You can find the affinity for DA reuptake however, under dopamine transporter.
Linkadge
Posted by SLS on September 15, 2006, at 7:42:03
In reply to DA-releasing information on PDSP?, posted by Keith Talent on September 15, 2006, at 4:05:57
> Hi everyone,
>
> Does anyone know how to get data on the dopamine-releasing properties of drugs from the PDSP (Psychoactive Drug Screening Program) website? I'm specifically interested in dextroamphetamine versus methylphenidate, but can't see any obvious way to extract these data. I'm interested to know because I think that the results may have implications for the sustainability of therapeutic benefits with these agents. Thanks,I think amphetamine results in greater and more sustained DA release as it releases DA from both storage vesicles and newly synthesized DA in the cytosol. Methylphenidate releases from vesicles only.
- Scott
Posted by Keith Talent on September 16, 2006, at 6:40:28
In reply to Re: DA-releasing information on PDSP?, posted by SLS on September 15, 2006, at 7:42:03
I'd already seen the data on DAT inhibition. Thanks everyone.
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.